Add time:08/04/2019         Source:sciencedirect.com

JMV 236, a new cholecystokinin-octapeptide-sulfate (CCK 8 S) derivative (Boc-Tyr (SO3)-Nle-Gly-Trp-Nle-Asp-Phe-NH2) has been synthesized in the Centre de Pharmacologie-Endocrinologie (Montpellier). This peptide has been shown to present the same activity as CCK 8 S on pancreatic amylase secretion and has the advantage of a better chemical stability.With a view to further characterization, the effect of JMV 236 on food intake and brain monoamine and metabolite variations was assayed in the rat after intraperitoneal (i.p.) and intracerebroventricular (i.c.v.) administrations.JMV 236 decreased food intake 2 and 3 hours after i.p. administration of 12.5 and 50 μg/kg but was inactive after i.c.v. injection. Its global action was similar to that of CCK 8 S, but was less marked with a delayed onset of response.As in our previous work with CCK 8 S, JMV 236 was more potent in inducing monoaminergic variations after i.p. than after i.c.v. administration. The main effects were decreases in striatal dopamine metabolite levels and increases in hypothalamic and striatal serotonin metabolite (5-HIAA) levels. These effects are classically observed with CCK 8 S and are described in our previous reports.The interesting peptide will require further characterization and may serve as a possible reference compound for studies on CCK derivatives.

We also recommend Trading Suppliers and Manufacturers of JMV 236 (cas 113137-57-8). Pls Click Website Link as below: cas 113137-57-8 suppliers